Return to our Home Page


Tech Resources
Data Sheet
Technical Bulletin
MSDS - English
Other Languages
Selected Citations
Certificate of Analysis
Store
-20°C-20°C
Ship
Shipped at Ambient TemperatureAmbient
Note: Store and Ship conditions may differ.
See Key
PubChem
SID: 26759319
Also available in:
bulkRequest a Quote!

Inhibitor Libraries

Inhibitor Email Sign Up

Kinase Kit Resource
  PD 98059
Cat. No. 513000  
All Categories » Calbiochem » Inhibitors » Kinase and Phosphatase » Mitogen Activated Protein Kinase (MAPK)

2′-Amino-3′-methoxyflavone

Pale yellow solid. PROTECT FROM LIGHT. Selective and cell-permeable inhibitor of MAP kinase kinase (MEK) that acts by inhibiting the activation of MAP kinase and subsequent phosphorylation of MAP kinase substrates. Pretreatment of PC-12 cells with PD 98059 completely blocks the 4-fold increase in MAP kinase activity produced by nerve growth factor (NGF; IC50 = 2 µM); however, it has no effect on NGF-dependent tyrosine phosphorylation of the p140trk receptor or its substrate Shc and does not block NGF-dependent activation of PI 3-kinase. Blocks LPS-induced activation of TNF-a gene expression. Inhibits cell growth and reverses the phenotype of ras-transformed BALB3T3 mouse fibroblasts and rat kidney cells. Purity: ≥98% by HPLC. CAS 167869-21-8.

Ref.: Means, T.K., et al. 2000. J. Leukoc. Biol. 67, 885. Kültz, D., et al. 1998. J. Biol. Chem. 273, 13645. Dudley, D.T., et al. 1995. Proc. Natl. Acad. Sci. USA 92, 7686. Langlois, W.J., et al. 1995. J. Biol. Chem. 270, 25320. Pang, L., et al. 1995. J. Biol. Chem. 270, 13585. Waters, S.B., et al. 1995. J. Biol. Chem. 270, 20883.

Need additional information about this product? Email our Technical Service department at: technical@calbiochem.com

 Related information for this product is available:

EMD Chemicals Inc. USD list price is displayed (pricing with local distributors may vary). NOTE: In Stock status is based on item availability worldwide.

Size
In Stock
Qty
Select Country Above
For Pricing Information
5 mgY$106.00


SolubilityMolecular FormulaMol. Wt.
DMSO or MeOH C16H13NO3 267.3 


Related Literature:

Protein Kinase and Related Tools Brochure

Inhibitor Sourcebook

Material Safety Data Sheets:
513000: PD 98059 - English
Bulgarian
Danish
Dutch
Finnish
French
German
Greek
Hungarian
Italian
Korean
Norwegian
Polish
Portuguese
Spanish
Swedish

Related Categories:
All Categories » Calbiochem » Inhibitors » Kinase and Phosphatase » Mitogen Activated Protein Kinase (MAPK)

Selected Citations:
  1. Joao B. Oliveira, et al. (2007) NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Procedings of the National Academy of Science 104, 8953-8958.
  2. Alexandra Thiel, Mira Heinonen, Johanna Rintahaka, Tuija Hallikainen, and Annabrita Hemmes, Dan A. Dixon, Caj Haglund, and Ari Ristimaki. (2006) EXPRESSION OF CYCLOOXYGENASE-2 IS REGULATED BY GSK-3 IN GASTRIC CANCER CELLS. Journal of Biological Chemistry in press,.
  3. Farahdiba Jafri, et al. (2006) Constitutive ERK1/2 activation by a chimeric neurokinin NK1 receptor-beta-arrestin1 fusion protein: Probing the composition and function of the G protein-coupled receptor 'signalsome'. Journal of Biological Chemistry in press,.
  4. Alexandra Thiel, et al. (2006) Expression of Cyclooxygenase-2 Is Regulated by Glycogen Synthase Kinase-3beta in Gastric Cancer Cells. Journal of Biological Chemistry 281, 4564-4569.
  5. Bysani Chandrasekar, et al. (2005) The pro-atherogenic cytokine interleukin-18 induces CXCL16 expression in rat aortic smooth muscle cells via MyD88, interleukin-1 receptor-associated kinase, tumor necrosis factor receptor-associated factor 6, c-Src, phosphatidylinositol 3-kinase, Akt, c-J. Journal of Biological Chemistry 280, 26263-26277.
  6. Diane Gesty-Palmer, et al. (2005) b-Arrestin 2 expression determines the transcriptional response to lysophosphatidic acid stimulation in murine embryo fibroblasts. Journal of Biological Chemistry 280, 32157-32167.
  7. Renee M. Marshall, et al. (2005) Cyclin T1 expression is regulated by multiple signaling pathways and mechanisms during activation of human peripheral blood lymphocytes. Journal of Immunology 175, 6402-6411.
  8. Wojciech Wojciechowski, et al. (2005) Enhanced Expression of CD20 in Human Tumor B Cells is Controlled Through ERK-Dependent Mechanisms. Journal of Immunology 174, 7859-7868.
  9. Yung-Luen Yu, et al. (2005) MAP kinase-mediated phosphorylation of GATA-1 promotes Bcl-XL expression and cell survival. Journal of Biological Chemistry 280, 29533-29542.
  10. Yona Goldshmit, et al. (2004) SOCS2 Induces Neurite Outgrowth by Regulation of Epidermal Growth Factor Receptor Activation. Journal of Biological Chemistry 279, 16349-16355.

...see all selected citations...